nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—polycystic ovary syndrome	0.901	1	CbGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—S100P—polycystic ovary syndrome	0.00637	0.138	CbGpPWpGaD
Lomefloxacin—CYP1A2—urine—polycystic ovary syndrome	0.00301	0.171	CbGeAlD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HELLS—polycystic ovary syndrome	0.00279	0.0603	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.00265	0.0572	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.00242	0.0523	CbGpPWpGaD
Lomefloxacin—Trovafloxacin—TOP2A—polycystic ovary syndrome	0.00208	0.212	CrCbGaD
Lomefloxacin—Acidosis—Metformin—polycystic ovary syndrome	0.00208	0.0827	CcSEcCtD
Lomefloxacin—TOP2A—G0 and Early G1—CCNE2—polycystic ovary syndrome	0.00201	0.0435	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.002	0.0434	CbGpPWpGaD
Lomefloxacin—TOP2A—G0 and Early G1—CDC6—polycystic ovary syndrome	0.00189	0.0409	CbGpPWpGaD
Lomefloxacin—Moxifloxacin—TOP2A—polycystic ovary syndrome	0.00158	0.161	CrCbGaD
Lomefloxacin—Fungal infection—Metformin—polycystic ovary syndrome	0.00149	0.0593	CcSEcCtD
Lomefloxacin—TOP2A—endometrium—polycystic ovary syndrome	0.00148	0.0845	CbGeAlD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00145	0.0315	CbGpPWpGaD
Lomefloxacin—TOP2A—uterus—polycystic ovary syndrome	0.00137	0.0779	CbGeAlD
Lomefloxacin—TOP2A—adipose tissue—polycystic ovary syndrome	0.00134	0.0762	CbGeAlD
Lomefloxacin—TOP2A—adrenal gland—polycystic ovary syndrome	0.0012	0.0683	CbGeAlD
Lomefloxacin—Pefloxacin—TOP2A—polycystic ovary syndrome	0.00115	0.117	CrCbGaD
Lomefloxacin—TOP2A—female gonad—polycystic ovary syndrome	0.00112	0.0637	CbGeAlD
Lomefloxacin—TOP2A—vagina—polycystic ovary syndrome	0.00111	0.0633	CbGeAlD
Lomefloxacin—Enoxacin—TOP2A—polycystic ovary syndrome	0.00108	0.11	CrCbGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SFTPC—polycystic ovary syndrome	0.00103	0.0222	CbGpPWpGaD
Lomefloxacin—Sparfloxacin—TOP2A—polycystic ovary syndrome	0.00099	0.101	CrCbGaD
Lomefloxacin—Ear pain—Metformin—polycystic ovary syndrome	0.000978	0.0389	CcSEcCtD
Lomefloxacin—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.000881	0.0501	CbGeAlD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000877	0.019	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—polycystic ovary syndrome	0.000859	0.0186	CbGpPWpGaD
Lomefloxacin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000855	0.034	CcSEcCtD
Lomefloxacin—ABCC2—adrenal gland—polycystic ovary syndrome	0.00082	0.0467	CbGeAlD
Lomefloxacin—SLC22A5—endometrium—polycystic ovary syndrome	0.000786	0.0447	CbGeAlD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.000742	0.016	CbGpPWpGaD
Lomefloxacin—SLC22A5—pituitary gland—polycystic ovary syndrome	0.000712	0.0405	CbGeAlD
Lomefloxacin—ABCC2—endocrine gland—polycystic ovary syndrome	0.000711	0.0405	CbGeAlD
Lomefloxacin—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000709	0.0403	CbGeAlD
Lomefloxacin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000702	0.028	CcSEcCtD
Lomefloxacin—Sweating increased—Metformin—polycystic ovary syndrome	0.000702	0.028	CcSEcCtD
Lomefloxacin—Levofloxacin—TOP2A—polycystic ovary syndrome	0.000697	0.071	CrCbGaD
Lomefloxacin—Ofloxacin—TOP2A—polycystic ovary syndrome	0.000697	0.071	CrCbGaD
Lomefloxacin—Ciprofloxacin—TOP2A—polycystic ovary syndrome	0.000673	0.0686	CrCbGaD
Lomefloxacin—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000636	0.0362	CbGeAlD
Lomefloxacin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00063	0.0251	CcSEcCtD
Lomefloxacin—SLC22A5—female gonad—polycystic ovary syndrome	0.000593	0.0337	CbGeAlD
Lomefloxacin—SLC22A5—vagina—polycystic ovary syndrome	0.000589	0.0335	CbGeAlD
Lomefloxacin—Bradycardia—Metformin—polycystic ovary syndrome	0.000588	0.0234	CcSEcCtD
Lomefloxacin—Rhinitis—Metformin—polycystic ovary syndrome	0.000579	0.023	CcSEcCtD
Lomefloxacin—Hepatitis—Metformin—polycystic ovary syndrome	0.000577	0.023	CcSEcCtD
Lomefloxacin—Norfloxacin—TOP2A—polycystic ovary syndrome	0.000565	0.0576	CrCbGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.000545	0.0118	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CLDN4—polycystic ovary syndrome	0.000539	0.0117	CbGpPWpGaD
Lomefloxacin—Flushing—Metformin—polycystic ovary syndrome	0.000536	0.0213	CcSEcCtD
Lomefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000524	0.0113	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE2—polycystic ovary syndrome	0.000522	0.0113	CbGpPWpGaD
Lomefloxacin—Chills—Metformin—polycystic ovary syndrome	0.000518	0.0206	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—polycystic ovary syndrome	0.000501	0.0108	CbGpPWpGaD
Lomefloxacin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000499	0.0284	CbGeAlD
Lomefloxacin—Flatulence—Metformin—polycystic ovary syndrome	0.000495	0.0197	CcSEcCtD
Lomefloxacin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000492	0.0196	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDC6—polycystic ovary syndrome	0.000491	0.0106	CbGpPWpGaD
Lomefloxacin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000483	0.0192	CcSEcCtD
Lomefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000477	0.0103	CbGpPWpGaD
Lomefloxacin—Tremor—Metformin—polycystic ovary syndrome	0.000471	0.0187	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000466	0.0186	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000461	0.00997	CbGpPWpGaD
Lomefloxacin—Malaise—Metformin—polycystic ovary syndrome	0.000453	0.018	CcSEcCtD
Lomefloxacin—Syncope—Metformin—polycystic ovary syndrome	0.000451	0.0179	CcSEcCtD
Lomefloxacin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000442	0.0176	CcSEcCtD
Lomefloxacin—Hypertension—Metformin—polycystic ovary syndrome	0.000434	0.0173	CcSEcCtD
Lomefloxacin—Myalgia—Metformin—polycystic ovary syndrome	0.000428	0.017	CcSEcCtD
Lomefloxacin—Chest pain—Metformin—polycystic ovary syndrome	0.000428	0.017	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.000426	0.00922	CbGpPWpGaD
Lomefloxacin—Discomfort—Metformin—polycystic ovary syndrome	0.000423	0.0168	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.000413	0.00893	CbGpPWpGaD
Lomefloxacin—Oedema—Metformin—polycystic ovary syndrome	0.00041	0.0163	CcSEcCtD
Lomefloxacin—Shock—Metformin—polycystic ovary syndrome	0.000403	0.0161	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000401	0.016	CcSEcCtD
Lomefloxacin—Skin disorder—Metformin—polycystic ovary syndrome	0.000398	0.0159	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000396	0.0158	CcSEcCtD
Lomefloxacin—Anorexia—Metformin—polycystic ovary syndrome	0.000391	0.0156	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—RRM2—polycystic ovary syndrome	0.000383	0.00829	CbGpPWpGaD
Lomefloxacin—Hypotension—Metformin—polycystic ovary syndrome	0.000383	0.0153	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000374	0.0149	CcSEcCtD
Lomefloxacin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000368	0.0147	CcSEcCtD
Lomefloxacin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000366	0.0146	CcSEcCtD
Lomefloxacin—Somnolence—Metformin—polycystic ovary syndrome	0.000365	0.0145	CcSEcCtD
Lomefloxacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000361	0.0144	CcSEcCtD
Lomefloxacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000356	0.0142	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000355	0.00769	CbGpPWpGaD
Lomefloxacin—Fatigue—Metformin—polycystic ovary syndrome	0.000354	0.0141	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000353	0.00763	CbGpPWpGaD
Lomefloxacin—Constipation—Metformin—polycystic ovary syndrome	0.000351	0.014	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000346	0.00748	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.000342	0.0074	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000338	0.0135	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000335	0.0134	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RAB2A—polycystic ovary syndrome	0.000333	0.00721	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000332	0.00717	CbGpPWpGaD
Lomefloxacin—Urticaria—Metformin—polycystic ovary syndrome	0.000326	0.013	CcSEcCtD
Lomefloxacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000324	0.0129	CcSEcCtD
Lomefloxacin—Norfloxacin—CYP1A1—polycystic ovary syndrome	0.000302	0.0308	CrCbGaD
Lomefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000301	0.00651	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RAB2A—polycystic ovary syndrome	0.000298	0.00645	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.000295	0.00639	CbGpPWpGaD
Lomefloxacin—Asthenia—Metformin—polycystic ovary syndrome	0.000294	0.0117	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNB1—polycystic ovary syndrome	0.00029	0.00628	CbGpPWpGaD
Lomefloxacin—Pruritus—Metformin—polycystic ovary syndrome	0.00029	0.0116	CcSEcCtD
Lomefloxacin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000281	0.0112	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000274	0.00592	CbGpPWpGaD
Lomefloxacin—Dizziness—Metformin—polycystic ovary syndrome	0.000271	0.0108	CcSEcCtD
Lomefloxacin—Vomiting—Metformin—polycystic ovary syndrome	0.000261	0.0104	CcSEcCtD
Lomefloxacin—Rash—Metformin—polycystic ovary syndrome	0.000259	0.0103	CcSEcCtD
Lomefloxacin—Dermatitis—Metformin—polycystic ovary syndrome	0.000258	0.0103	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.000258	0.00558	CbGpPWpGaD
Lomefloxacin—Headache—Metformin—polycystic ovary syndrome	0.000257	0.0102	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000253	0.00547	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000253	0.00546	CbGpPWpGaD
Lomefloxacin—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000252	0.00545	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000246	0.00533	CbGpPWpGaD
Lomefloxacin—Nausea—Metformin—polycystic ovary syndrome	0.000244	0.0097	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000242	0.00524	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000223	0.00482	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.000218	0.00472	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.000211	0.00457	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000205	0.00444	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000193	0.00417	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.000192	0.00415	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE2—polycystic ovary syndrome	0.000191	0.00414	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00019	0.00411	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000187	0.00404	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.00018	0.0039	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00018	0.00389	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDC6—polycystic ovary syndrome	0.00018	0.00389	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000176	0.00381	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000174	0.00376	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCNE2—polycystic ovary syndrome	0.000171	0.0037	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000165	0.00357	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000164	0.00354	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000163	0.00352	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000162	0.0035	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000162	0.0035	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDC6—polycystic ovary syndrome	0.000161	0.00348	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00016	0.00347	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000159	0.00345	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000156	0.00336	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000146	0.00317	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000143	0.00309	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000142	0.00306	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RRM2—polycystic ovary syndrome	0.000141	0.00304	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000133	0.00287	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000133	0.00287	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—polycystic ovary syndrome	0.000133	0.00287	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000131	0.00284	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00013	0.00281	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000129	0.0028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000129	0.0028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000129	0.0028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000128	0.00277	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RRM2—polycystic ovary syndrome	0.000126	0.00272	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000124	0.00269	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—polycystic ovary syndrome	0.000123	0.00267	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000121	0.00262	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAD2L1—polycystic ovary syndrome	0.000119	0.00257	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000114	0.00247	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000113	0.00244	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—LMNA—polycystic ovary syndrome	0.00011	0.00239	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCNB1—polycystic ovary syndrome	0.000107	0.0023	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000105	0.00227	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000105	0.00226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000103	0.00223	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000103	0.00223	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	9.86e-05	0.00213	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCNB1—polycystic ovary syndrome	9.52e-05	0.00206	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	9.29e-05	0.00201	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	9.18e-05	0.00199	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	8.64e-05	0.00187	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.57e-05	0.00185	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.47e-05	0.00183	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.45e-05	0.00183	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	8.13e-05	0.00176	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.9e-05	0.00171	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.79e-05	0.00169	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.59e-05	0.00164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.49e-05	0.00162	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	7.38e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.07e-05	0.00153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.06e-05	0.00153	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.96e-05	0.00151	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.8e-05	0.00147	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.63e-05	0.00143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	6.43e-05	0.00139	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	6.43e-05	0.00139	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.32e-05	0.00137	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.32e-05	0.00137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	6.06e-05	0.00131	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.78e-05	0.00125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.58e-05	0.00121	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.51e-05	0.00119	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	5.39e-05	0.00117	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	5.11e-05	0.0011	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	4.9e-05	0.00106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	4.87e-05	0.00105	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.85e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.5e-05	0.000974	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.44e-05	0.00096	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	4.14e-05	0.000896	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	3.96e-05	0.000856	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	3.78e-05	0.000817	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	3.69e-05	0.000799	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	3.62e-05	0.000783	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	3.62e-05	0.000783	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	3.58e-05	0.000773	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	3.37e-05	0.000728	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	3.36e-05	0.000726	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.29e-05	0.000712	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.07e-05	0.000664	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.91e-05	0.00063	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	2.86e-05	0.000619	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.86e-05	0.000619	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.75e-05	0.000595	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.71e-05	0.000586	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.4e-05	0.000519	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.27e-05	0.000492	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.17e-05	0.000469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.14e-05	0.000464	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.93e-05	0.000418	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.84e-05	0.000399	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.82e-05	0.000394	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.73e-05	0.000374	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.68e-05	0.000364	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.64e-05	0.000356	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.59e-05	0.000344	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.47e-05	0.000317	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.42e-05	0.000307	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.37e-05	0.000296	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.31e-05	0.000284	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.31e-05	0.000283	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.3e-05	0.000281	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.29e-05	0.000279	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.23e-05	0.000265	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.21e-05	0.000261	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.04e-05	0.000226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.02e-05	0.00022	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.55e-06	0.000207	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.52e-06	0.000184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	8.12e-06	0.000176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.7e-06	0.000167	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.18e-06	0.000155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.82e-06	0.000126	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.74e-06	0.000124	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.71e-06	0.000123	CbGpPWpGaD
